Contracts › W81K0025FA195
W81K0025FA195: Lutathera and Pluvicto
Awarded to Novartis Pharmaceuticals Corporation by Department of the Army.
$3.2Mobligated
$3.2Mpotential value
30 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | W81K0025FA195 |
|---|---|
| Vehicle | W81K0024D0004 |
| Awardee | Novartis Pharmaceuticals Corporation |
| Awarding agency | Department of the Army |
| Awarding office | W40M MRC0 WEST |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | TX |
| Period of performance | 01 October 2025 to 30 September 2026 |
| Potential end | 30 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record